Funded Project Details - FY2021
|Title:|| GVHD quantitative assessment in skin of Veterans post-HCT|
|Congressional District Code:
||Clinical Science R&D
|| January 2019 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Chronic graft-versus-host disease (cGVHD) is the leading cause of nonrelapse mortality following allogeneic hematopoietic stem cell transplantation (HCT). Once the diagnosis is made, a fundamental practice gap remains the determination of whether disease is stable or progressing. Clinical trials of promising new potential treatments are limited by the lack of reproducible and sensitive measures of cGVHD severity. Skin is central to cGVHD evaluation because it is the most commonly involved organ...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.